Literature DB >> 18497063

AKT regulates androgen receptor-dependent growth and PSA expression in prostate cancer.

Margarita Mikhailova1, Yu Wang, Roble Bedolla, Xiao-Hua Lu, Jeffrey I Kreisberg, Paramita M Ghosh.   

Abstract

Recurrent prostate cancer (PC) is usually treated with androgen deprivation therapy, which, despite initial success, eventually fails due to the development of androgen-independent PC. Androgen deprivation stimulates a significant increase in the phosphorylation (activation) of Akt, a serine/threonine kinase, which regulates cell growth and survival. Hence, we asked whether the increase in Akt phosphorylation contributes to the development of androgen independence. Akt regulates transcriptional activity of the androgen receptor (AR), and our data show that Akt-stimulated AR transcriptional activity is dependent on androgen-binding to the AR. PC proliferation has both androgen-sensitive and insensitive components. The androgen sensitive component is Akt-dependent, while the androgen-insensitive is not. However, Akt-induced cell survival is largely AR independent, suggesting that the cell stimulates Akt phosphorylation when subjected to androgen deprivation as an alternate pathway to maintain survival.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18497063     DOI: 10.1007/978-0-387-69080-3_38

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  15 in total

1.  The profile of prostate epithelial cytokines and its impact on sera prostate specific antigen levels.

Authors:  Yosra Bouraoui Mechergui; Awatef Ben Jemaa; Chekib Mezigh; Benito Fraile; Nawfel Ben Rais; Ricardo Paniagua; Mar Royuela; Ridha Oueslati
Journal:  Inflammation       Date:  2009-04-28       Impact factor: 4.092

2.  Nrdp1-mediated regulation of ErbB3 expression by the androgen receptor in androgen-dependent but not castrate-resistant prostate cancer cells.

Authors:  Liqun Chen; Salma Siddiqui; Swagata Bose; Benjamin Mooso; Alfredo Asuncion; Roble G Bedolla; Ruth Vinall; Clifford G Tepper; Regina Gandour-Edwards; Xubao Shi; Xiao-Hua Lu; Javed Siddiqui; Arul M Chinnaiyan; Rohit Mehra; Ralph W Devere White; Kermit L Carraway; Paramita M Ghosh
Journal:  Cancer Res       Date:  2010-06-29       Impact factor: 12.701

3.  RelB-dependent differential radiosensitization effect of STI571 on prostate cancer cells.

Authors:  Yong Xu; Fang Fang; Yulan Sun; Daret K St Clair; William H St Clair
Journal:  Mol Cancer Ther       Date:  2010-04-06       Impact factor: 6.261

4.  Androgen Receptor regulation of Vitamin D receptor in response of castration-resistant prostate cancer cells to 1α-Hydroxyvitamin D5 - a calcitriol analog.

Authors:  Benjamin Mooso; Anisha Madhav; Sherra Johnson; Mohana Roy; Mary E Moore; Christabel Moy; Grace A Loredo; Rajendra G Mehta; Andrew T M Vaughan; Paramita M Ghosh
Journal:  Genes Cancer       Date:  2010-11-16

5.  Dual EGFR/HER2 inhibition sensitizes prostate cancer cells to androgen withdrawal by suppressing ErbB3.

Authors:  Liqun Chen; Benjamin A Mooso; Maitreyee K Jathal; Anisha Madhav; Sherra D Johnson; Elyse van Spyk; Margarita Mikhailova; Alexandra Zierenberg-Ripoll; Lingru Xue; Ruth L Vinall; Ralph W deVere White; Paramita M Ghosh
Journal:  Clin Cancer Res       Date:  2011-08-15       Impact factor: 12.531

6.  Functional cyclic AMP response element in the breast cancer resistance protein (BCRP/ABCG2) promoter modulates epidermal growth factor receptor pathway- or androgen withdrawal-mediated BCRP/ABCG2 transcription in human cancer cells.

Authors:  Yi Xie; Takeo Nakanishi; Karthika Natarajan; Lowell Safren; Anne W Hamburger; Arif Hussain; Douglas D Ross
Journal:  Biochim Biophys Acta       Date:  2015-01-21

7.  Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines.

Authors:  Yu Wang; Todd Romigh; Xin He; Mohammed S Orloff; Robert H Silverman; Warren D Heston; Charis Eng
Journal:  Hum Mol Genet       Date:  2010-08-20       Impact factor: 6.150

8.  Edelfosine Promotes Apoptosis in Androgen-Deprived Prostate Tumors by Increasing ATF3 and Inhibiting Androgen Receptor Activity.

Authors:  Thirupandiyur S Udayakumar; Radka Stoyanova; Mohammed M Shareef; Zhaomei Mu; Sakhi Philip; Kerry L Burnstein; Alan Pollack
Journal:  Mol Cancer Ther       Date:  2016-03-04       Impact factor: 6.261

9.  Downregulation of key regulatory proteins in androgen dependent prostate tumor cells by oncolytic reovirus.

Authors:  Pooja Gupta-Saraf; Tyler Meseke; Cathy L Miller
Journal:  Virology       Date:  2015-08-08       Impact factor: 3.616

10.  Structure-based virtual screening and identification of a novel androgen receptor antagonist.

Authors:  Chin-Hee Song; Su Hui Yang; Eunsook Park; Suk Hee Cho; Eun-Yeung Gong; Daulat Bikram Khadka; Won-Jea Cho; Keesook Lee
Journal:  J Biol Chem       Date:  2012-07-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.